This Live Medscape Social Media Event explores the shared strategies for managing immunologic diseases across specialties, with a focus on integrating newer targeted therapies such as Janus kinase (JAK) inhibitors into patient-centered care. Healthcare professionals will learn to develop treatment approaches that align with patients' goals and preferences while overcoming common barriers to optimal care. The program addresses the varying confidence levels among specialists, will enhance their ab

Precision oncology is moving fast. Are you keeping up? We are launching the Precision Oncology Learning Center soon. It will be your go-to hub for independent CME, global expert insights, and the latest data in one place. Hear from Steering Committee Chair Fabrice Andre, MD, PhD, on why centralized information matters for better outcomes. 🔗 Visit the learning center here: http://ms.spr.ly/6185slxpL | Medscape

Chronic Myeloid Leukemia: Harmonizing Clinical Trial Data With Clinical Practice | Medscape

Oral TKI or IV ADC for HER2 NSCLC? The first oral medication for this disease, Zongertinib, is now approved, joining established IV therapies like Trastuzumab deruxtecan. Our experts discuss how to choose ▶️ https://www.facebook.com/events/566988496426095 #Oncology #CME | Medscape

Looking to improve outcomes for patients with advanced COPD/emphysema? This free Medscape CME provides practical guidance on identifying and supporting candidates for endobronchial valve treatment. | Pulmonx